Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONC.TO | HBP.TO | METX.CN | ||
| Company | Oncolytics Bio | Helix Biopharm | ME Therapeutics Holdings Inc. | ||
| Price Information | |||||
| Exchange | TSX | TSX | CNSX | ||
| Open | 1.42 | 1.88 | 3.7000 | ||
| High | 1.44 | 2.00 | 3.7000 | ||
| Low | 1.39 | 1.80 | 2.5000 | ||
| Latest | 1.42 | 2.00 | 2.5000 | ||
| Change | +0.03 | unch | unch | ||
| % Change | +2.16% | unch | unch | ||
| Volume | 109,627 | 1,802 | 800 | ||
| 20-Day Average Volume | 310,431 | 1,862 | 640 | ||
| Previous Close | 1.39 | 2.00 | 2.5000 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.36 | 2.01 | 2.7450 | ||
| 20-Day Raw Stochastic | 69.05% | 43.10% | 28.57% | ||
| 20-Day Relative Strength | 54.28 | 46.83 | 43.19 | ||
| Weighted Alpha | -41.60 | +14.73 | -62.40 | ||
| Today's Opinion | 80% Buy | 8% Sell | 100% Sell | ||
| Previous Opinion | 80% Buy | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.70% since 08/15/25 | +8.70% since 02/10/26 | -16.39% since 02/13/26 | ||
| Low | 1.33 on 08/20/25 | 1.80 on 02/23/26 | 2.5000 on 02/24/26 | ||
| High | 1.48 on 08/18/25 | 2.00 on 02/23/26 | 3.7400 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | -14.97% since 07/22/25 | -4.76% since 01/23/26 | -16.67% since 01/23/26 | ||
| Low | 1.13 on 08/08/25 | 1.78 on 02/10/26 | 2.0000 on 02/13/26 | ||
| High | 1.68 on 07/23/25 | 2.28 on 01/29/26 | 3.7500 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | +153.57% since 05/22/25 | -13.79% since 11/21/25 | -33.33% since 11/24/25 | ||
| Low | 0.44 on 06/06/25 | 1.75 on 01/20/26 | 2.0000 on 02/13/26 | ||
| High | 1.85 on 07/17/25 | 2.45 on 01/08/26 | 4.0000 on 12/19/25 | ||
| 6-Month | |||||
| %Chg | +37.86% since 02/21/25 | +48.15% since 08/22/25 | -37.50% since 08/22/25 | ||
| Low | 0.44 on 06/06/25 | 1.25 on 08/27/25 | 2.0000 on 02/13/26 | ||
| High | 1.85 on 07/17/25 | 5.40 on 10/06/25 | 8.0000 on 10/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 142,513 | 152,756 | 75,124 | ||
| Shares Outstanding, K | 100,361 | 76,378 | 30,049 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -31,710,000 | -5,205,000 | -1,193,200 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -14,400,000 | -1,008,000 | -354,433 | ||
| 60-Month Beta | 0.80 | 0.32 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | -0.01 on 12/12/25 | -0.01 on 01/28/26 | ||
| Latest Earnings Date | 03/06/26 | 03/13/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||